Caregiver Mastery Linked to Patient Survival in Glioblastoma

Caregiver Mastery Linked to Patient Survival in Glioblastoma
Caregiver Mastery Linked to Patient Survival in Glioblastoma

Caregiver mastery appears to be associated with overall survival among patients with newly diagnosed glioblastoma multiforme, according to a study published in the journal Cancer.1

Patients with glioblastoma multiforme typically have a poor prognosis and often rely heavily on family caregivers for both emotional and physical support. Therefore, the capability and mental health of family caregivers may affect their ability to provide care and impact patient outcomes.

To examine whether caregivers' anxiety, depressive symptoms, burden, and mastery influenced survival in patients with new diagnoses of this deadly form of brain cancer, researchers analyzed data from 88 pairs of caregivers and patients participating in a longitudinal study funded by the National Institutes of Health.

The study showed that median overall survival among patients was 14.5 months, with survival ranging from 0 to 88 months.

After controlling for confounding factors, researchers found that caregiver mastery was independently associated with patient survival. Specifically, each unit increase in mastery was associated with a 16.1% reduction in the risk of patient death (95% CI, 0.771-0.913; P <.001).

Further studies are needed to validate these findings. If these results are supported in future studies, it may be important to provide neuro-oncology caregivers with more structured support and guidance with the ultimate goal of improving patients' well-being and outcomes.

Reference

1. Boele FW, Given CW, Given BA, et al. Family caregivers' level of mastery predicts survival of patients with glioblastoma: a preliminary report. Cancer. 2016 Oct 27. doi: 10.1002/cncr.30428. [Epub ahead of print]

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs